4:16 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Filana Therapeutics Nasdaq/NYSE Compliance Notice
Filana Therapeutics received a deficiency notice from Nasdaq on September 17, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 calendar days, until March 16, 2027, to regain compliance by having its stock close at or above $1.00 for at least 10 consecutive business days.
- Counterparty
- Nasdaq Stock Market, LLC
- Term
- 180 days